z-logo
open-access-imgOpen Access
Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies
Author(s) -
Zhen Wang,
Abulikemu Maimaitiaili,
Tengfei Wang,
Xinghua Song
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s304864
Subject(s) - in vivo , rifapentine , polylactic acid , in vitro , pharmacology , tuberculosis , drug delivery , medicine , chemistry , pathology , biochemistry , latent tuberculosis , biology , mycobacterium tuberculosis , microbiology and biotechnology , organic chemistry , polymer
Spinal tuberculosis has been a common clinical extrapulmonary tuberculosis in recent years. The general anti-tuberculosis drug treatment cycle is long, with unsatisfactory efficacy. This study focused on the preparation and evaluation of rifapentine polylactic acid sustained-release microsphere complex for spinal tuberculosis therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here